Rajiv Gandhi Cancer Institute and Research Centre

Rajiv Gandhi Cancer Institute and Research Centre (RGCIRC) is a non-profit medical facility and research institute based in Delhi, India specialising in cancer treatment and research. It is one of the largest medical centers for cancer treatment in Asia. RGCIRC is a project of Indraprastha Cancer Society and Research Centre, a not-for-profit public society. The institute was founded in 1996.
History and overview.
Indraprastha Cancer Society and Research Centre is a not for profit public medical society. It was formed in the year 1994 under the society's registration act, 1860. The Institute started functioning on 1 July 1996 when a soft opening was done by Sonia Gandhi. However, it was formally inaugurated by the then, President of India, Shankar Dayal Sharma, in the presence of Sonia Gandhi and others on 20 August 1996. It started as a 152 bedded hospital, and currently it's a 302 bedded hospital. The institute diagnoses and treats around 60,000 patients per year. Since its establishment, the institute has provided services to over two hundred thousand patients from India, Nepal, Bangladesh, Sri Lanka, and other countries. The Institute is ISO:9001 and ISO:14001 certified. In February 2013, the institute introduced electrical technology as a service called 'NanoKnife', a minimally invasive cancer treatment. On 12 October 2016, a new cancer center was established in NitiBagh, South Delhi by the institute.
Departments and facilities.
The medical center is spread around two hundred thousand square feet area, with a bed capacity of 500. The 57 consultation rooms are spread on three floors of the institute. It has 14 state-of-the-art modular Operation Theatres with three stage air filtration and gas scavenging systems, and 2 Minor Operation Theatres for Day Care Surgeries. The Surgical ICU is 51 bedded and Medical ICU is 21 bedded. The institute has Leukemia ward, Thyroid Ward, Bone Marrow Transplant unit, MUD transplant unit, and stem cell transplant unit. It has facilities of Renal Replacement therapies and various endoscopies.
Academics and research.
Besides patients care, the institute also studies and undertakes scientific research on the aspects of cancer and in particular to investigate its incidence, prevalence, distribution, cause, symptoms and to promote its prevention and provides cure. The institute has partnership with Thomas Jefferson University. 